FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/03/064794 [Registered on: 27/03/2024] Trial Registered Prospectively
Last Modified On: 26/03/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   COMPARISON OF MEDICINES TO STUDY EFFECTS LIKE BLOOD PRESSURE, HEART RATE VARIATIONS AND SENSORY AND MOTOR CHARACTERISTICS IN SPINAL ANAESTHESIA  
Scientific Title of Study   A COMPARATIVE STUDY OF INTRATHECAL DEXMEDETOMIDINE VERSUS CLONIDINE AS ADJUVANT TO 0.75% HYPERBARIC ROPIVACAINE IN INFRA UMBILICAL SURGERIES :A RANDOMISED CLINICAL TRIAL 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Soumya Patted 
Designation  Post graduate resident  
Affiliation  Bangalore Medical College and Research Institute, RGUHS University, Karnataka  
Address  Department of Anesthesiology Banglore Medical College and Research institute Fort, Krishna Rajendra Rd, Kalasipalya, Bengaluru, Karnataka 560002

Bangalore
KARNATAKA
560002
India 
Phone  8884839682  
Fax    
Email  soumyacp121@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Samudyatha T J 
Designation  Assistant Professor  
Affiliation  Bangalore Medical College and Research Institute  
Address  Department of Anesthesiology Banglore Medical College and Research institute Fort, Krishna Rajendra Rd, Kalasipalya, Bengaluru, Karnataka 560002

Bangalore
KARNATAKA
560002
India 
Phone  9686216626  
Fax    
Email  drsamudyatha@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Samudyatha T J 
Designation  Assistant Professor  
Affiliation  Bangalore Medical College and Research Institute  
Address  Department of Anesthesiology Banglore Medical College and Research institute Fort, Krishna Rajendra Rd, Kalasipalya, Bengaluru, Karnataka 560002

Bangalore
KARNATAKA
560002
India 
Phone  9686216626  
Fax    
Email  drsamudyatha@gmail.com  
 
Source of Monetary or Material Support  
Bangalore Medical College and Research Institute , Fort, Krishna Rajendra Rd, Kalasipalya, Bengaluru, Karnataka, India PIN -560002. 
 
Primary Sponsor  
Name  Dr Soumya Patted  
Address  Bangalore Medical College and Research Institute Fort, Krishna Rajendra Rd, Kalasipalya, Bengaluru, Karnataka 560002 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Soumya Patted   Bangalore Medical College and Research Institute   Department of Anesthesiology
Bangalore
KARNATAKA 
8884839682

soumyacp121@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Bangalore Medical College and Research Institute   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M859||Disorder of bone density and structure, unspecified, (2) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  0.75% hyperbaric Ropivacaine 3ml + Clonidine 50 mcg   After adequate preoperative evaluation, patient will be brought inside operation theatre.Blood pressure, ECG leads, pulse oximeter will be connected. Intravenous fluids will be started. Patient will be made to sit and spinal anaesthesia will be given in L3-L4 intervertebral space with 25 gauge Quincke spinal needle using 3 ml 0.75% hyperbaric ropivacaine and clonidine 50 mcg. Intrathecal drug will be given over 10-15 seconds and patient will be made to lie supine immediately after giving drug and that time will be taken as 0. Drug will be given only once and it will take 10-15 seconds to administer.Route of administration is intrathecal( subarachnoid space)  
Intervention  0.75% hyperbaric Ropivacaine 3ml + dexmedetomidine 5 mcg  After adequate preoperative evaluation, patient will be brought inside operation theatre.Blood pressure, ECG leads, pulse oximeter will be connected. Intravenous fluids will be started. Patient will be made to sit and spinal anaesthesia will be given in L3-L4 intervertebral space with 25 gauge Quincke spinal needle using 3 ml 0.75% hyperbaric ropivacaine and dexmedetomidine 5 mcg. Intrathecal drug will be given over 10-15 seconds and patient will be made to lie supine immediately after giving drug and that time will be taken as 0. Drug will be given only once and it will take 10-15 seconds to administer.Route of administration is intrathecal( subarachnoid space) 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details 
1. Patients of age group 18-60 years undergoing infraumbilical surgeries under supbarchnoid block.
2. Patients willing to give written informed consent
3. Patients belonging to ASA I and II 
 
ExclusionCriteria 
Details   
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
1) To compare the block characteristics of intrathecal Dexmedetomidine versus Clonidine as an adjuvant to 0.75% Hyperbaric Ropivacaine in terms of the onset and duration of sensory block and motor block
2) To compare the duration of post operative analgesia  
From time of intrathecal injection to every 30 seconds till the loss of sensation at T10 dermatomal level and thereafter at 2 mins intervals till the maximum level of sensory blockade is achieved and subsequently at 30 mins interval until complete recovery.
From time of intrathecal injection every 1 minute for the first 5 min, then at 5-min intervals for next 30 minutes and at every 30 minutes intervals until complete resolution of motor anesthesia.
 
 
Secondary Outcome  
Outcome  TimePoints 
to compare effects of dexmedetomidine and clonidine on hemodynamic parameters, sedation and adverse effects.
 
Before spinal anaesthesia, after spinal anaesthesia every 2 minutes for first 10 minutes, then every 5 minutes for 30 minutes, thereafter every 10 minutes till end of surgery .
Immediate post operative period, every 2 hours for 6 hours, 12 hours and 24 hours  
 
Target Sample Size   Total Sample Size="70"
Sample Size from India="70" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Post Marketing Surveillance 
Date of First Enrollment (India)   06/04/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="30" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary      70 patients will be randomly grouped by computer generated numbers and assigned to one of the two groups:
Group RD (n=35) will receive 0 .75% hyperbaric Ropivacaine 3 ml + Dexmedetomidine 5 mcg
Group RC (n=35) will receive 0 .75% hyperbaric Ropivacaine 3 ml + Clonidine 50 mcg intrathecally.
Data will be collected in the case record proforma meeting the objectives of the study. Pre anaesthetic evaluation will be done for each patient and written informed consent will be taken. All patients will be fasted 8 hours for solid food and 4 hours for clear fluids. Intravenous line will be obtained with 18-gauge cannula and will be preloaded with Ringer lactate at 15 ml/kg body weight about 20 minutes before anaesthesia. Patients will be monitored with pulse oximetry( spO2), electrocardiography (ECG), non- invasive blood pressure (NIBP).Under aseptic precautions lumbar puncture will be performed at the level of L3- L4 intervertebral space through a midline approach using 25 G Quincke’s spinal needle and study drug will be injected after confirmation of needle tip in the subarachnoid space by clear and free flow of cerebrospinal fluid.
Patients will be randomly divided into 2 groups by computer generated random sequence table (www.randomization.com)namely Group RD and Group RC in a sealed envelope with labelled syringe. Drug will be given by anaesthetist not involved in study.Intrathecal injection will be given over approximately 10-15seconds. Patients wil be made to lie in supine position immediately. All the things will be kept ready for general anesthesia if needed. Table will be kept in neutral position. All the patients wil be given oxygen by Hudson mask at 6 Litres/minute. The time of intrathecal injection will be noted and taken as 0 minute.
Patients will be monitored with ECG ,NIBP ,SPO2 and respiratory rate at regular intervals of every 5 minutes and continued in the post-operative period.When Visual Analogue Scale(VAS)of >4 or when patient desires rescue analgesic (Paracetamol)will be given
Sensory blockade will be tested using pin prick method with a blunt 27 Gauge hypodermic needle along midclavicular line bilaterally every 30 seconds till the loss of sensation at T10 dermatomal level and thereafter at 2 mins intervals till the maximum level of sensory blockade is achieved and subsequently at 30 mins interval until complete recovery.
Motor block will be assessed by using a Modified Bromage Scale every 1 minute for the first 5 min, then at 5-min intervals for next 30 minutes and at every 30 minutes intervals until complete resolution of motor  block.Parameters assessed will be BP, HR, SpO2, RR , onset ,duration and maximum level of sensory and motor block , duration of analgesia and sedation, rescue analgesic requirement. All these parameters will beonitered both intra  and postoperative period 
 
Close